S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
How major US stock indexes fared Friday 6/9/2023
MarketBeat Week in Review – 6/4 - 6/9
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
Kevin O'Leary Slams Martha Stewart's Comments on Remote Work: 'Nobody Wants to Work in These Places'
FuelCell Is Back To Realistic Valuation
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
New Mexico reaches $500M settlement with Walgreens in opioid case
With GM and Ford embracing Tesla's EV charging technology, here's what it means for consumers
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
How major US stock indexes fared Friday 6/9/2023
MarketBeat Week in Review – 6/4 - 6/9
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
Kevin O'Leary Slams Martha Stewart's Comments on Remote Work: 'Nobody Wants to Work in These Places'
FuelCell Is Back To Realistic Valuation
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
New Mexico reaches $500M settlement with Walgreens in opioid case
With GM and Ford embracing Tesla's EV charging technology, here's what it means for consumers
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
How major US stock indexes fared Friday 6/9/2023
MarketBeat Week in Review – 6/4 - 6/9
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
Kevin O'Leary Slams Martha Stewart's Comments on Remote Work: 'Nobody Wants to Work in These Places'
FuelCell Is Back To Realistic Valuation
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
New Mexico reaches $500M settlement with Walgreens in opioid case
With GM and Ford embracing Tesla's EV charging technology, here's what it means for consumers
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
How major US stock indexes fared Friday 6/9/2023
MarketBeat Week in Review – 6/4 - 6/9
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
Kevin O'Leary Slams Martha Stewart's Comments on Remote Work: 'Nobody Wants to Work in These Places'
FuelCell Is Back To Realistic Valuation
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
New Mexico reaches $500M settlement with Walgreens in opioid case
With GM and Ford embracing Tesla's EV charging technology, here's what it means for consumers
NASDAQ:VERO

Venus Concept (VERO) Stock Forecast, Price & News

$2.54
+0.09 (+3.67%)
(As of 06/9/2023 ET)
Compare
Today's Range
$2.47
$2.59
50-Day Range
$2.10
$3.84
52-Week Range
$2.06
$11.70
Volume
13,248 shs
Average Volume
52,292 shs
Market Capitalization
$13.84 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

VERO stock logo

About Venus Concept (NASDAQ:VERO) Stock

Venus Concept, Inc. develops, commercializes and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related practice enhancement services. Its product portfolio consists of aesthetic device platforms which includes venus versa, venus legacy, venus velocity, venus fiore, venus viva, venus freeze plus, and venus bliss. The company was founded on November 22, 2002 and is headquartered in Toronto, Canada.

Receive VERO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Venus Concept and its competitors with MarketBeat's FREE daily newsletter.

VERO Stock News Headlines

Venus Concept (VERO) Gets a Hold from Maxim Group
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
Venus Concept Inc. (NASDAQ:VERO) Short Interest Update
Venus Concept (NASDAQ:VERO) Stock Rating Lowered by Maxim Group
Venus Concept (VERO) to Release Earnings on Monday
Venus Concept's Earnings: A Preview
VenusConcept Strides on Launching ARTAS iX
See More Headlines

VERO Price History

VERO Company Calendar

Last Earnings
5/15/2023
Today
6/10/2023
Next Earnings (Estimated)
8/11/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:VERO
Fax
N/A
Employees
407
Year Founded
N/A

Profitability

Net Income
$-43,700,000.00
Pretax Margin
-48.42%

Debt

Sales & Book Value

Annual Sales
$93.62 million
Book Value
$1.77 per share

Miscellaneous

Free Float
2,652,000
Market Cap
$13.86 million
Optionable
Not Optionable
Beta
1.80

Key Executives

  • Rajiv de Silva
    Chief Executive Officer & Director
  • Hermanth Jacob Varghese
    President, Chief Innovation & Business Officer
  • Domenic Della Penna
    Chief Financial Officer
  • William H. McGrail
    Senior VP-Technical Operations & Compliance
  • Yoni IgerYoni Iger
    Vice President-Clinical & Regulatory Affairs













VERO Stock - Frequently Asked Questions

Should I buy or sell Venus Concept stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Venus Concept in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" VERO shares.
View VERO analyst ratings
or view top-rated stocks.

How have VERO shares performed in 2023?

Venus Concept's stock was trading at $4.80 at the beginning of 2023. Since then, VERO shares have decreased by 47.1% and is now trading at $2.54.
View the best growth stocks for 2023 here
.

When is Venus Concept's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, August 11th 2023.
View our VERO earnings forecast
.

How were Venus Concept's earnings last quarter?

Venus Concept Inc. (NASDAQ:VERO) announced its quarterly earnings data on Monday, May, 15th. The company reported ($1.85) earnings per share for the quarter. The business had revenue of $20.53 million for the quarter. Venus Concept had a negative trailing twelve-month return on equity of 426.69% and a negative net margin of 47.79%.

When did Venus Concept's stock split?

Venus Concept's stock reverse split before market open on Friday, May 12th 2023. The 1-15 reverse split was announced on Friday, May 12th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 12th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

What guidance has Venus Concept issued on next quarter's earnings?

Venus Concept updated its FY 2023 earnings guidance on Friday, May, 26th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $90.00 million-$95.00 million, compared to the consensus revenue estimate of $91.37 million.

What other stocks do shareholders of Venus Concept own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Venus Concept investors own include Spectrum Pharmaceuticals (SPPI), CONSOL Energy (CEIX), Salesforce (CRM), Cisco Systems (CSCO), SCYNEXIS (SCYX), AzurRx BioPharma (AZRX), Boeing (BA), Interpace Biosciences (IDXG), Johnson & Johnson (JNJ) and Advanced Micro Devices (AMD).

What is Venus Concept's stock symbol?

Venus Concept trades on the NASDAQ under the ticker symbol "VERO."

Who are Venus Concept's major shareholders?

Venus Concept's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Commonwealth Equity Services LLC (0.23%). Insiders that own company stock include Anna Georgiadis, Anthony Natale, Chad A Zaring, Domenic Serafino, Healthquest Partners Ii, LP, Keith J Sullivan, Penna Domenic Della, Ross Portaro, Sedco Capital Cayman Ltd, Silva Rajiv De, Stanley Tyler Hollmig and Yoni Iger.
View institutional ownership trends
.

How do I buy shares of Venus Concept?

Shares of VERO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Venus Concept's stock price today?

One share of VERO stock can currently be purchased for approximately $2.54.

How much money does Venus Concept make?

Venus Concept (NASDAQ:VERO) has a market capitalization of $13.86 million and generates $93.62 million in revenue each year. The company earns $-43,700,000.00 in net income (profit) each year or ($9.65) on an earnings per share basis.

How many employees does Venus Concept have?

The company employs 407 workers across the globe.

How can I contact Venus Concept?

Venus Concept's mailing address is 235 YORKLAND BLVD SUITE 900, TORONTO A6, M2J 4Y8. The official website for the company is www.venusconcept.com. The company can be reached via phone at (888) 907-0115 or via email at venusconceptir@westwicke.com.

This page (NASDAQ:VERO) was last updated on 6/10/2023 by MarketBeat.com Staff

My Account -